
    
      Patients with primary CDAD will be approached for consent and randomized equally to two arms:
      oral FMT with oral Vancomycin placebo, or oral FMT placebo with oral Vancomycin. FMT will be
      prepared from anonymous donors screened according to Health Canada guidelines and stored
      frozen.
    
  